Prosecution Insights
Last updated: April 18, 2026

Sagimet Biosciences Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18535291 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS BORALSKY, LUKE ALAN 1624 Final Rejection Dec 11, 2023

Managing Sagimet Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month